Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Oxypurinol
Cat. No.:
0225LY-1420
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Oxypurinol functions as an inhibitor of xanthine oxidase and is regarded as a potential therapeutic candidate for managing congestive heart failure.
Synonym:
2465-59-0
CAS No.:
2465-59-0
Formula:
C5H4N4O2
Formula Weight:
152.11
Specification
Relative Density:
2.19 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Oxypurinol can be used in enzyme research to investigate the inhibition of xanthine oxidase and its role in purine metabolism.
Library Information
Target:
Xanthine oxidase
Receptor:
Xanthine oxidase
Pathways:
Metabolism; Immunology/Inflammation
Plate Number:
AOCL-19
Plate Location:
c3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
10 mg/mL; 65.74 mM
